Wall Street closes with losses on recession woes - Breaking The News
Download our appPlay StoreApp Store

Wall Street closes with losses on recession woes

EPA-EFE/JUSTIN LANE

Major Wall Street equities ended the trading session on Monday recording losses, with the downturn trend seemingly driven by recession fears as the Federal Reserve warns of more aggressive monetary tightening that could push the economy into a slowdown. Furthermore, the rise in yields on the country's Treasury notes may have contributed to the negative sentiment that dragged the Wall Street indices down.

The Dow Jones Industrial Average plunged by 1.10% or 325 points at the closing bell, sinking 19.48% year to date. Travelers Companies Inc. was the index's worst performer, declining by 3.14%. The Nasdaq 100 dipped by 0.51%, as Charter Communications Inc. nosedived by 4.81%. The S&P 500 closed the session, plummeting by 1.02%, falling to the lowest level since December 2020. DISH Network Corporation pulled the index down by 6.12%.

The euro slipped 0.79% against the American currency, selling at $0.96089 at 3:58 pm ET.

Related News
Harris slams Trump for 'admiring dictators'
United States Vice President Kamala Harris, the Democratic presidential nominee, spoke in a recent NBC News interview about the choice Americans face in the upcoming election. She contrasted herself with former President Donald Trump, saying that voters must decide whether they want a leader who she claims openly admires authoritarian figures or not. "The American people are being presented with a choice here about whether we want a president who...
Moderna sued for patent infringement over COVID-19 vaccines
Northwestern University launched a lawsuit against Modern Inc. in Delaware federal court, accusing it of using the university's innovations to roll out its COVID-19 vaccine, Spikevax, without a license.Northwestern stressed that Moderna completed the first clinical trial of its COVID-19 vaccine a month before the World Health Organization declared the coronavirus outbreak a pandemic, adding that the pharmaceutical company "could not have achieved this...
Moderna gets greenlight for updated COVID jab
Moderna Inc. shared on Tuesday that it has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for its updated coronavirus vaccine, which targets the JN.1 variant of SARS-CoV-2."COVID-19 continues to present a serious health risk. Updated vaccines targeting circulating strains play a vital role in helping to protect those most at risk from severe illness and hospitalization, alleviating strain on the NHS," Britain's...
FDA greenlights updated Novavax COVID vaccine
The United States Food and Drug Administration (FDA) approved on Friday the emergency use of the Novavax COVID-19 vaccine for "individuals 12 years of age and older." The approval allows those previously vaccinated to receive one dose, while those who haven't been vaccinated will need two. Similar to the Moderna and Pfizer vaccines, this updated version specifically targets the omicron variant JN.1 of the virus while providing increased protection against...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.